{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:24Z","timestamp":1787003724190,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2705605, to Qian Zhu"],"award-info":[{"award-number":["2023YFC2705605, to Qian Zhu"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2703302"],"award-info":[{"award-number":["2022YFC2703302"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2021YFS0078"],"award-info":[{"award-number":["2021YFS0078"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73183-4","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T10:03:42Z","timestamp":1727431422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical strategy study on prenatal screening and diagnostic model for Down syndrome"],"prefix":"10.1038","volume":"14","author":[{"given":"Wei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiwen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fene","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosha","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cechuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"73183_CR1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/AOG.0000000000004107","volume":"136","author":"Screening for Fetal Chromosomal Abnormalities","year":"2020","unstructured":"Screening for Fetal Chromosomal Abnormalities. ACOG Practice Bulletin Summary, Number 226. Obstet. Gynecol.  136, 859\u2013867 (2020).","journal-title":"Obstet. Gynecol."},{"key":"73183_CR2","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa043693","volume":"353","author":"FD Malone","year":"2005","unstructured":"Malone, F. D. et al. First-trimester or second-trimester screening, or both, for Down\u2019s syndrome. N Engl. J. Med. 353, 2001\u20132011 (2005).","journal-title":"N Engl. J. Med."},{"key":"73183_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1186\/s12884-020-03464-z","volume":"20","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Wang, X., Li, L., Lu, S. & Zhang, Z. New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age. BMC Pregnancy Childbirth. 20, 776 (2020).","journal-title":"BMC Pregnancy Childbirth"},{"key":"73183_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/(SICI)1097-0223(199708)17:8<707::AID-PD142>3.0.CO;2-H","volume":"17","author":"JJ Hsu","year":"1997","unstructured":"Hsu, J. J., Hsieh, T. T., Soong, Y. K. & Spencer, K. Comparison of Down\u2019s syndrome screening strategies in asians combining serum free beta-hCG and alpha-fetoprotein with maternal age. Prenat Diagn. 17, 707\u2013716 (1997).","journal-title":"Prenat Diagn."},{"key":"73183_CR5","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0002-9378(97)70400-9","volume":"176","author":"GE Palomaki","year":"1997","unstructured":"Palomaki, G. E., Knight, G. J., McCarthy, J. E., Haddow, J. E. & donhowe, J. M. Maternal serum screening for Down syndrome in the United States: a 1995 survey. Am. J. Obstet. Gynecol. 176, 1046\u20131051 (1997).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"73183_CR6","first-page":"1056","volume":"18","author":"AR Gregg","year":"2016","unstructured":"Gregg, A. R. et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet. Sci. 18, 1056\u20131065 (2016).","journal-title":"Genet. Sci."},{"key":"73183_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YMD Lo","year":"1997","unstructured":"Lo, Y. M. D. et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 350, 485\u2013487 (1997).","journal-title":"Lancet"},{"key":"73183_CR8","doi-asserted-by":"publisher","first-page":"c7401","DOI":"10.1136\/bmj.c7401","volume":"342","author":"RWK Chiu","year":"2011","unstructured":"Chiu, R. W. K. et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Bmj. 342, c7401\u2013c7401 (2011).","journal-title":"Bmj"},{"key":"73183_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/uog.14792","volume":"45","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies. Ultrasound Obstet. Gynecol. 45, 530\u2013538 (2015).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"73183_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40246-020-00268-2","volume":"14","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China. Hum. Genomics. 14, 21 (2020).","journal-title":"Hum. Genomics"},{"key":"73183_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1159\/000523738","volume":"49","author":"NC Prodan","year":"2022","unstructured":"Prodan, N. C. et al. Universal Cell Free DNA or Contingent Screening for Trisomy 21: does it make a difference? A comparative study with Real Data. Fetal Diagn. Ther. 49, 85\u201394 (2022).","journal-title":"Fetal Diagn. Ther."},{"key":"73183_CR12","doi-asserted-by":"publisher","first-page":"870543","DOI":"10.3389\/fpubh.2022.870543","volume":"10","author":"S Wang","year":"2022","unstructured":"Wang, S., Liu, K., Yang, H. & Ma, J. A cost-effectiveness analysis of screening strategies involving non-invasive prenatal testing for Trisomy 21. Front. Public. Health. 10, 870543 (2022).","journal-title":"Front. Public. Health"},{"key":"73183_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1515\/jpm-2021-0467","volume":"50","author":"H Cuckle","year":"2022","unstructured":"Cuckle, H., Heinonen, S., Anttonen, A. K. & Stefanovic, V. Cost of providing cell-free DNA screening for Down syndrome in Finland using different strategies. J. Perinat. Med. 50, 233\u2013243 (2022).","journal-title":"J. Perinat. Med."},{"key":"73183_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12884-019-2434-0","volume":"19","author":"MA Sanchez-Duran","year":"2019","unstructured":"Sanchez-Duran, M. A. et al. Clinical application of a contingent screening strategy for trisomies with cell-free DNA: a pilot study. BMC Pregnancy Childbirth. 19, 274 (2019).","journal-title":"BMC Pregnancy Childbirth"},{"key":"73183_CR15","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1186\/s12913-019-4699-4","volume":"19","author":"C Wanapirak","year":"2019","unstructured":"Wanapirak, C., Buddhawongsa, P., Himakalasa, W., Sarnwong, A. & Tongsong, T. Fetal Down syndrome screening models for developing countries; part II: cost-benefit analysis. BMC Health Serv. Res. 19, 898 (2019).","journal-title":"BMC Health Serv. Res."},{"key":"73183_CR16","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jogc.2017.01.025","volume":"39","author":"T Huang","year":"2017","unstructured":"Huang, T., Meschino, W. S., Teitelbaum, M., Dougan, S. & Okun, N. Enhanced First Trimester Screening for Trisomy 21 with contingent cell-free fetal DNA: a comparative performance and cost analysis. J. Obstet. Gynaecol. Can. 39, 742\u2013749 (2017).","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"73183_CR17","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.gim.2022.11.004","volume":"25","author":"JS Dungan","year":"2023","unstructured":"Dungan, J. S. et al. Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet. Med. 25, 100336 (2023).","journal-title":"Genet. Med."},{"key":"73183_CR18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/pd.6357","volume":"43","author":"L Hui","year":"2023","unstructured":"Hui, L. et al. Position statement from the International Society for Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies. Prenat. Diagn. 43, 814\u2013828 (2023).","journal-title":"Prenat. Diagn."},{"key":"73183_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/uog.14693","volume":"45","author":"MI Evans","year":"2015","unstructured":"Evans, M. I., Sonek, J. D., Hallahan, T. W. & Krantz, D. A. Cell-free fetal DNA screening in the USA: a cost analysis of screening strategies. Ultrasound Obstet. Gynecol. 45, 74\u201383 (2015).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"73183_CR20","doi-asserted-by":"crossref","unstructured":"Morris, S., Karlsen, S., Chung, N., Hill, M. & Chitty, L. S. Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down\u2019s syndrome using cell free fetal DNA in the UK National Health Service. PLoS ONE; 9. (2014).","DOI":"10.1371\/journal.pone.0093559"},{"key":"73183_CR21","doi-asserted-by":"crossref","unstructured":"Neyt, M., Hulstaert, F. & Gyselaers, W. Introducing the non-invasive prenatal test for trisomy 21 in Belgium: a cost-consequences analysis. BMJ Open.; 4. (2014).","DOI":"10.1136\/bmjopen-2014-005922"},{"key":"73183_CR22","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3109\/14767058.2015.1038703","volume":"29","author":"G Fairbrother","year":"2016","unstructured":"Fairbrother, G., Burigo, J., Sharon, T. & Song, K. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis. J. Maternal-Fetal Neonatal Med. 29, 1160\u20131164 (2016).","journal-title":"J. Maternal-Fetal Neonatal Med."},{"key":"73183_CR23","doi-asserted-by":"crossref","unstructured":"Walker, B. S. et al. A cost-effectiveness analysis of first trimester non-invasive prenatal screening for fetal trisomies in the United States. Plos One; 10. (2015).","DOI":"10.1371\/journal.pone.0131402"},{"key":"73183_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/pd.4511","volume":"35","author":"BS Walker","year":"2015","unstructured":"Walker, B. S., Jackson, B. R., LaGrave, D., Ashwood, E. R. & Schmidt, R. L. A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome. Prenat. Diagn. 35, 440\u2013446 (2015).","journal-title":"Prenat. Diagn."},{"key":"73183_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/pd.6296","volume":"43","author":"KRM van der Meij","year":"2023","unstructured":"van der Meij, K. R. M., Henneman, L. & Sistermans, E. A. Non-invasive prenatal testing for everybody or contingent screening? Prenat Diagn. 43, 443\u2013447 (2023).","journal-title":"Prenat Diagn."},{"key":"73183_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/pd.6131","volume":"42","author":"B Bowden","year":"2022","unstructured":"Bowden, B. et al. Implementation of non-invasive prenatal testing within a national UK antenatal screening programme: impact on women\u2019s choices. Prenat Diagn. 42, 549\u2013556 (2022).","journal-title":"Prenat Diagn."},{"key":"73183_CR27","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41436-021-01101-4","volume":"23","author":"K Van Den Bogaert","year":"2021","unstructured":"Van Den Bogaert, K. et al. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet. Med. 23, 1137\u20131142 (2021).","journal-title":"Genet. Med."},{"key":"73183_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12884-020-03279-y","volume":"20","author":"L Yang","year":"2020","unstructured":"Yang, L. & Tan, W. C. Prenatal screening in the era of non-invasive prenatal testing: a nationwide cross-sectional survey of obstetrician knowledge, attitudes and clinical practice. BMC Pregnancy Childbirth. 20, 579 (2020).","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73183-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73183-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73183-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T14:02:48Z","timestamp":1727704968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73183-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73183"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73183-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22269"}}